Dr. Francis Collins retires from NIH, urging support for crucial research and embattled workers
Collins, a renowned geneticist and former longtime director of the National Institutes of Health, announced Saturday that he ...
Axios on MSN8 小时
Former NIH director Francis Collins retires
Former National Institutes of Health Director Francis Collins unexpectedly retired on Friday, writing in a statement that ...
Yahoo Finance6 天
CRISPR Therapeutics AG (CRSP)
Take CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA), two biotechs specializing in gene editing. Finance, is $83.60; the latter earns a price target of $50.80 from ...
C&EN3 天
Advancing CRISPR/Cas Biosensing with Integrated Devices
Rather than being famous only in the gene editing field, by revealing the collateral cleavage activity of Cas12a, Cas13a, and Cas14 effectors, Clustered Regularly Interspaced Short Palindromic Repeats ...
Nature19 天
CRISPR-Cas systems articles from across Nature Portfolio
CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...
The New York Times1 天
Book Review
By Matt Bell Our columnist reviews three new horror books out this month. By Gabino Iglesias ...